Baxter: FMR LLC Discloses 9.0% Stake
Baxter International Inc. — Amendment to Schedule 13G reporting institutional ownership.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Baxter International Inc. — Amendment to Schedule 13G reporting institutional ownership.
FMR LLC (with Abigail P. Johnson disclosed) reports 46,264,804.28 shares of Common Stock, representing 9.0% of the class as of 03/31/2026. The filing shows sole dispositive power for 46,264,804.28 shares and sole voting power of 32,385,962.16 shares. The amendment is signed 05/05/2026 and references an attached Exhibit 99 and a power of attorney.
Insights
FMR LLC reports a 9.0% beneficial stake in Baxter as of 03/31/2026.
The filing documents that FMR LLC holds 46,264,804.28 shares with sole dispositive authority and materially less sole voting power (32,385,962.16 shares). This indicates control over disposition decisions while voting authority is partially allocated.
Cash‑flow treatment and any underlying trading plans are not stated; subsequent filings or the referenced exhibits may clarify subsidiary attributions and arrangements.
Key Figures
Key Terms
Schedule 13G/A regulatory
beneficially owned financial
13d-1(k)(1) agreement regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does FMR LLC report in BAX?
Who else is named in the filing with FMR LLC for BAX ownership?
What voting and dispositive powers are reported?
Where can I find more detail about the subsidiary or agreement referenced?
AI-generated analysis. How Rhea-AI works. Not financial advice.